is headache a side effect of tirzepatide Effects: Common & Rare Reactions Explained Can Weight Loss Injections Cause

Metzler-Wilson K, Toma K, Sammons DL, et al

It was released as a blood glucose control treatment for patients with diabetes, but it was approved for use as an obesity treatment by the US Food and Drug Administration (FDA) in 2014, as it was found to be effective for weight loss without hypoglycemia in obese people who did not have diabetes

GLP-1 usage is set to move beyond the 9% of UK early adopters who are currently using it or have used it in the past, with an additional 18% of UK adults saying they would consider it

A combination approach

Diet and discipline With GLP-1 treatments reducing appetite, users are encouraged to make every meal count focusing on whole, nutrient-dense foods rich in protein, fiber, and healthy fats